Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evan Loh Insider Profile
4 Followers
Evan Loh, CEO, Director at Paratek Pharmaceuticals, holds 0.00 shares in Paratek Pharmaceuticals (Ticker: PRTK), holds 14.00K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds ― shares in Windtree Therapeutics (Ticker: WINT).
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-5.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Evan Loh holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 15, 2021 - Mar 15, 2022
Return:+46.30%
The most profitable trade made by Evan Loh
Evan Loh's Trading History
Paratek Pharmaceuticals
Sep 21, 2023
―
Uninformative Sell
―
$0.00
Eiger Biopharmaceuticals
Mar 11, 2022
Director
Uninformative Buy
―
$34.02K
Windtree Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Evan Loh's performance on stock
You May Also Like
Evan Loh insider profile FAQ
What is the percentage of profitable transactions made by Evan Loh?
The percentage of profitable transactions made by Evan Loh is 38%.
What is the average return per transaction made by Evan Loh?
The average return per transaction made by Evan Loh is -5.00%.
What stocks does Evan Loh hold?
Evan Loh holds: PRTK, EIGRQ, WINT stocks.
What was Evan Loh’s latest transaction?
Evan Loh latest transaction was an Uninformative Sell of ―.
What was Evan Loh's most profitable transaction?
Evan Loh’s most profitable transaction was an Informative Sell of EIGRQ stock on March 15, 2021. The return on the trade was 46.30%.
What is Evan Loh's role in Paratek Pharmaceuticals?
Evan Loh's role in Paratek Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.